US Stock MarketDetailed Quotes

TARO Taro Pharmaceutical Industries

Watchlist

0.000
0.0000.00%

Close Jul 24 09:30 ET

0Market Cap0.00P/E (TTM)

Taro Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

9.81%629.18M

12.52%164.94M

12.89%157.15M

13.57%148.2M

1.42%158.89M

2.07%572.95M

2.32%146.59M

0.16%139.2M

-1.13%130.5M

6.49%156.67M

Operating revenue

9.81%629.18M

12.52%164.94M

12.89%157.15M

13.57%148.2M

1.42%158.89M

2.07%572.95M

2.32%146.59M

0.16%139.2M

-1.13%130.5M

6.49%156.67M

Cost of revenue

6.43%324.23M

9.41%77.55M

2.81%77.26M

-10.70%74.6M

26.31%94.81M

13.57%304.63M

7.52%70.88M

19.39%75.16M

19.44%83.54M

8.13%75.06M

Gross profit

13.65%304.96M

15.43%87.39M

24.72%79.88M

56.73%73.6M

-21.47%64.08M

-8.46%268.32M

-2.12%75.71M

-15.77%64.05M

-24.31%46.96M

5.03%81.61M

Operating expense

13.11%283.47M

18.32%78.61M

1.96%64M

28.05%68.86M

6.47%72.01M

48.98%250.61M

18.49%66.43M

60.77%62.77M

48.64%53.78M

83.14%67.63M

Selling and administrative expenses

10.37%218.94M

15.96%58.13M

1.10%50.41M

29.07%54.54M

-0.47%55.86M

74.50%198.37M

21.74%50.13M

100.72%49.86M

78.41%42.26M

134.08%56.12M

-Selling and marketing expense

----

100.07%113.28M

----

-General and administrative expense

----

49.12%85.09M

----

Research and development costs

23.53%64.54M

25.59%20.48M

5.28%13.59M

24.33%14.33M

40.29%16.15M

-4.21%52.24M

9.50%16.31M

-9.11%12.91M

-7.79%11.52M

-11.15%11.51M

Operating profit

21.29%21.49M

-5.28%8.78M

1,141.83%15.88M

169.55%4.74M

-156.68%-7.92M

-85.82%17.71M

-56.41%9.27M

-96.54%1.28M

-126.35%-6.82M

-65.72%13.98M

Net non-operating interest income expense

169.51%56.19M

97.04%15.83M

135.07%15.5M

225.23%13.97M

465.42%10.89M

154.67%20.85M

1,071.43%8.04M

215.41%6.59M

81.19%4.3M

-36.69%1.93M

Non-operating interest income

154.23%56.19M

70.46%15.83M

135.07%15.5M

225.23%13.97M

465.42%10.89M

124.62%22.1M

297.14%9.29M

215.41%6.59M

81.19%4.3M

-36.69%1.93M

Non-operating interest expense

----

-24.20%1.25M

----

Other net income (expense)

1,521.65%4.99M

172.88%1.61M

51.04%1.97M

55.83%-1.06M

1,537.75%2.47M

99.36%-351K

-80.67%590K

209.76%1.3M

-302.11%-2.39M

100.25%151K

Gain on sale of security

100.32%9K

-25.37%-588K

-81.30%138K

41.79%-1.62M

808.50%2.08M

-241.71%-2.81M

-118.46%-469K

235.66%738K

-1,156.06%-2.79M

-6.91%-294K

Special income (charges)

----

--0

----

Other non- operating income (expenses)

102.32%4.98M

107.55%2.2M

224.51%1.83M

43.29%566K

-12.36%390K

-41.76%2.46M

106.43%1.06M

-43.13%563K

-83.12%395K

15.89%445K

Income before tax

116.33%82.67M

46.53%26.23M

263.54%33.34M

459.35%17.66M

-66.11%5.44M

-50.92%38.21M

-28.45%17.9M

-76.78%9.17M

-116.70%-4.91M

199.84%16.05M

Income tax

125.57%28.8M

1.48%11.15M

588.83%13.14M

533.71%9.11M

-332.67%-4.59M

-34.83%12.77M

560.09%10.99M

-85.54%1.91M

-134.40%-2.1M

-26.56%1.97M

Net income

111.70%53.87M

118.11%15.08M

178.16%20.21M

403.84%8.55M

-28.74%10.03M

-56.33%25.45M

-74.77%6.91M

-72.39%7.27M

-112.06%-2.81M

175.02%14.08M

Net income continuous Operations

111.70%53.87M

118.11%15.08M

178.16%20.21M

403.84%8.55M

-28.74%10.03M

-56.33%25.45M

-74.77%6.91M

-72.39%7.27M

-112.06%-2.81M

175.02%14.08M

Minority interest income

Net income attributable to the parent company

111.70%53.87M

118.11%15.08M

178.16%20.21M

403.84%8.55M

-28.74%10.03M

-56.33%25.45M

-74.77%6.91M

-72.39%7.27M

-112.06%-2.81M

175.02%14.08M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

111.70%53.87M

118.11%15.08M

178.16%20.21M

403.84%8.55M

-28.74%10.03M

-56.33%25.45M

-74.77%6.91M

-72.39%7.27M

-112.06%-2.81M

175.02%14.08M

Basic earnings per share

110.29%1.43

122.22%0.4

184.21%0.54

428.57%0.23

-27.03%0.27

-56.13%0.68

-75.34%0.18

-72.86%0.19

-111.29%-0.07

174.00%0.37

Diluted earnings per share

110.29%1.43

122.22%0.4

184.21%0.54

428.57%0.23

-27.03%0.27

-56.13%0.68

-75.34%0.18

-72.86%0.19

-111.29%-0.07

174.00%0.37

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	9.81%629.18M	12.52%164.94M	12.89%157.15M	13.57%148.2M	1.42%158.89M	2.07%572.95M	2.32%146.59M	0.16%139.2M	-1.13%130.5M	6.49%156.67M
Operating revenue	9.81%629.18M	12.52%164.94M	12.89%157.15M	13.57%148.2M	1.42%158.89M	2.07%572.95M	2.32%146.59M	0.16%139.2M	-1.13%130.5M	6.49%156.67M
Cost of revenue	6.43%324.23M	9.41%77.55M	2.81%77.26M	-10.70%74.6M	26.31%94.81M	13.57%304.63M	7.52%70.88M	19.39%75.16M	19.44%83.54M	8.13%75.06M
Gross profit	13.65%304.96M	15.43%87.39M	24.72%79.88M	56.73%73.6M	-21.47%64.08M	-8.46%268.32M	-2.12%75.71M	-15.77%64.05M	-24.31%46.96M	5.03%81.61M
Operating expense	13.11%283.47M	18.32%78.61M	1.96%64M	28.05%68.86M	6.47%72.01M	48.98%250.61M	18.49%66.43M	60.77%62.77M	48.64%53.78M	83.14%67.63M
Selling and administrative expenses	10.37%218.94M	15.96%58.13M	1.10%50.41M	29.07%54.54M	-0.47%55.86M	74.50%198.37M	21.74%50.13M	100.72%49.86M	78.41%42.26M	134.08%56.12M
-Selling and marketing expense	----	----	----	----	----	100.07%113.28M	----	----	----	----
-General and administrative expense	----	----	----	----	----	49.12%85.09M	----	----	----	----
Research and development costs	23.53%64.54M	25.59%20.48M	5.28%13.59M	24.33%14.33M	40.29%16.15M	-4.21%52.24M	9.50%16.31M	-9.11%12.91M	-7.79%11.52M	-11.15%11.51M
Operating profit	21.29%21.49M	-5.28%8.78M	1,141.83%15.88M	169.55%4.74M	-156.68%-7.92M	-85.82%17.71M	-56.41%9.27M	-96.54%1.28M	-126.35%-6.82M	-65.72%13.98M
Net non-operating interest income expense	169.51%56.19M	97.04%15.83M	135.07%15.5M	225.23%13.97M	465.42%10.89M	154.67%20.85M	1,071.43%8.04M	215.41%6.59M	81.19%4.3M	-36.69%1.93M
Non-operating interest income	154.23%56.19M	70.46%15.83M	135.07%15.5M	225.23%13.97M	465.42%10.89M	124.62%22.1M	297.14%9.29M	215.41%6.59M	81.19%4.3M	-36.69%1.93M
Non-operating interest expense	----	----	----	----	----	-24.20%1.25M	----	----	----	----
Other net income (expense)	1,521.65%4.99M	172.88%1.61M	51.04%1.97M	55.83%-1.06M	1,537.75%2.47M	99.36%-351K	-80.67%590K	209.76%1.3M	-302.11%-2.39M	100.25%151K
Gain on sale of security	100.32%9K	-25.37%-588K	-81.30%138K	41.79%-1.62M	808.50%2.08M	-241.71%-2.81M	-118.46%-469K	235.66%738K	-1,156.06%-2.79M	-6.91%-294K
Special income (charges)	----	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	102.32%4.98M	107.55%2.2M	224.51%1.83M	43.29%566K	-12.36%390K	-41.76%2.46M	106.43%1.06M	-43.13%563K	-83.12%395K	15.89%445K
Income before tax	116.33%82.67M	46.53%26.23M	263.54%33.34M	459.35%17.66M	-66.11%5.44M	-50.92%38.21M	-28.45%17.9M	-76.78%9.17M	-116.70%-4.91M	199.84%16.05M
Income tax	125.57%28.8M	1.48%11.15M	588.83%13.14M	533.71%9.11M	-332.67%-4.59M	-34.83%12.77M	560.09%10.99M	-85.54%1.91M	-134.40%-2.1M	-26.56%1.97M
Net income	111.70%53.87M	118.11%15.08M	178.16%20.21M	403.84%8.55M	-28.74%10.03M	-56.33%25.45M	-74.77%6.91M	-72.39%7.27M	-112.06%-2.81M	175.02%14.08M
Net income continuous Operations	111.70%53.87M	118.11%15.08M	178.16%20.21M	403.84%8.55M	-28.74%10.03M	-56.33%25.45M	-74.77%6.91M	-72.39%7.27M	-112.06%-2.81M	175.02%14.08M
Minority interest income						0
Net income attributable to the parent company	111.70%53.87M	118.11%15.08M	178.16%20.21M	403.84%8.55M	-28.74%10.03M	-56.33%25.45M	-74.77%6.91M	-72.39%7.27M	-112.06%-2.81M	175.02%14.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	111.70%53.87M	118.11%15.08M	178.16%20.21M	403.84%8.55M	-28.74%10.03M	-56.33%25.45M	-74.77%6.91M	-72.39%7.27M	-112.06%-2.81M	175.02%14.08M
Basic earnings per share	110.29%1.43	122.22%0.4	184.21%0.54	428.57%0.23	-27.03%0.27	-56.13%0.68	-75.34%0.18	-72.86%0.19	-111.29%-0.07	174.00%0.37
Diluted earnings per share	110.29%1.43	122.22%0.4	184.21%0.54	428.57%0.23	-27.03%0.27	-56.13%0.68	-75.34%0.18	-72.86%0.19	-111.29%-0.07	174.00%0.37
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall